Adherence to HIV post-exposure prophylaxis in victims of sexual assault: A systematic review and meta-analysis

Sexually Transmitted Infections

Volumn 88, Issue 5, 2012, Pages 335-341

  Chacko, Liza ^a   Ford, Nathan ^b,c   Sbaiti, Mariam ^a   Siddiqui, Ruby ^b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b MÉDECINS SANS FRONTIÈRES   (Switzerland)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; INDINAVIR; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; ZALCITABINE; ZIDOVUDINE;

ARTICLE; DEVELOPING COUNTRY; HEALTH CARE DISPARITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATIENT COMPLIANCE; POST EXPOSURE PROPHYLAXIS; PRIORITY JOURNAL; SEXUAL CRIME;

CHEMOPREVENTION; HIV INFECTIONS; HUMANS; MEDICATION ADHERENCE; POST-EXPOSURE PROPHYLAXIS; RAPE;

EID: 84864285464     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sextrans-2011-050371     Document Type: Article

References (46)

1. DeGruttola V, Seage GR 3rd, Mayer KH, et al. Infectiousness of HIV between male homosexual partners. J Clin Epidemiol 1989;42:849-56. (Pubitemid 19231951)
2. Downs AM, De Vincenzi I. Probability of heterosexual transmission of HIV: relationship to the number of unprotected sexual contacts. European Study Group in Heterosexual Transmission of HIV. J Acquir Immune Defic Syndr Hum Retrovirol 1996;11:388-95. (Pubitemid 126448572)
3. Linden JA, Oldeg P, Mehta SD, et al. HIV postexposure prophylaxis in sexual assault: current practice and patient adherence to treatment recommendations in a large urban teaching hospital. Acad Emerg Med 2005;12:640-6. (Pubitemid 40827137)
4. Speight CG, Klufio A, Kilonzo SN, et al. Piloting post-exposure prophylaxis in Kenya raises specific concerns for the management of childhood rape. Trans R Soc Trop Med Hyg 2006;100:14-18. (Pubitemid 41700184)
5. World Health Organization. Post-Exposure Prophylaxis to Prevent HIV Infection: Joint WHO/ILO Guidelines on Post-Exposure Prophylaxis (PEP) to Prevent HIV Infection. Geneva: WHO Press, 2007.
6. Myles JE, Hirozawa A, Katz MH, et al. Postexposure prophylaxis for HIV after sexual assault. JAMA 2000;284:1516-18.
7. Wiebe ER, Comay SE, McGregor M, et al. Offering HIV prophylaxis to people who have been sexually assaulted: 16 months' experience in a sexual assault service. CMAJ 2000;162:641-5. (Pubitemid 30151470)
8. Olshen E, Hsu K, Woods ER, et al. Use of human immunodeficiency virus postexposure prophylaxis in adolescent sexual assault victims. Arch Pediatr Adolesc Med 2006;160:674-80.
9. Kerr E. The Haven: a pilot referral centre in London for cases of serious sexual assault. BJOG 2003;110:267-71. (Pubitemid 36298909)
10. Templeton DJ, Davies SC, Garvin AL, et al. The uptake of HIV post-exposure prophylaxis within a sexual assault setting in Sydney, Australia. Int J STD AIDS 2005;16:108-11. (Pubitemid 40313203)
11. Kahn JO, Martin JN, Roland ME, et al. Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study. J Infect Dis 2001;183:707-14. (Pubitemid 32171744)
12. Schechter M, do Lago RF, Mendelsohn AB, et al. Behavioral impact, acceptability, and HIV incidence among homosexual men with access to postexposure chemoprophylaxis for HIV. J Acquir Immune Defic Syndr 2004;35:519-25. (Pubitemid 38420661)
13. Rothbaum BO, Foa EB, Riggs DS, et al. A prospective examination of post-traumatic stress disorder in rape victims. J Trauma Stress 1992;5:455-75.
14. Martin SL, Young SK, Billings DL, et al. Health care-based interventions for women who have experienced sexual violence: a review of the literature. Trauma Violence Abuse 2007;8:3-18.
15. Loutfy MR, Macdonald S, Myhr T, et al. Prospective cohort study of HIV post-exposure prophylaxis for sexual assault survivors. Antivir Ther 2008;13:87-95. (Pubitemid 351541677)
16. Kim JC, Martin LJ, Denny L. Rape and HIV post-exposure prophylaxis: addressing the dual epidemics in South Africa. Reprod Health Matters 2003;11:101-12. (Pubitemid 37466344)
17. Sanderson S, Tatt ID, Higgins JP. Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. Int J Epidemiol 2007;36:666-76. (Pubitemid 47244573)
18. Jüni P, Witschi A, Bloch R, et al. The hazards of scoring the quality of clinical trials for metaanalysis. JAMA 1999;282:1054-60. (Pubitemid 29436453)
19. Borenstien M, Hedges L, Higgins JP, et al. Introduction to Meta-analysis. Chichester: John Wiley & Sons, 2008:312.
20. MacDonald R. 2nd Joint Conference of the British HIV Association and the British Association for Sexual Health and HIV Manchester United Kingdom, 2010. Conference publication: (Var.Pagings). HIV Med 2010;11:51.
21. Masanzu R, Ajayi C, Sibly E, et al. Conference: 2nd Joint Conference of the British HIV Association and the British Association for Sexual Health and HIV Manchester United Kingdom. Conference Start: 20100420 Conference End: 20100423. Conference Publication: (Var.Pagings). HIV Med 2010;11:53.
22. Bani-Sadr F, Teissiere F, Curie I, et al. [Anti-infection prophylaxis after sexual assault. Experience of the Raymond Poincare-Garches Hospital] (In French). Presse Med 2001;30:253-8.
23. Du Mont J, Myhr TL, Husson H, et al. HIV postexposure prophylaxis use among Ontario female adolescent sexual assault victims: a prospective analysis. Sex Transm Dis 2008;35:973-8.
24. Roland ME, Myer L, Martin LJ, et al. Preventing human immunodeficiency virus infection among sexual assault survivors in Cape Town, South Africa: an observational study. AIDS Behav 2012;16:990-8.
25. Carries S, Muller F, Muller FJ, et al. Characteristics, treatment, and antiretroviral prophylaxis adherence of South African rape survivors. J Acquir Immune Defic Syndr 2007;46:68-71. (Pubitemid 47507436)
26. Rey D, Bendiane MK, Bouhnik AD, et al. Physicians' and patients' adherence to antiretroviral prophylaxis after sexual exposure to HIV: results from South-Eastern France. AIDS Care 2008;20:537-41.
27. Wong K, Hughes CA, Plitt S, et al. HIV non-occupational postexposure prophylaxis in a Canadian province: treatment completion and follow-up testing. Int J STD AIDS 2010;21:617-21.
28. Limb S, Kawsar M, Forster GE. HIV post-exposure prophylaxis after sexual assault: the experience of a sexual assault service in London. Int J STD AIDS 2002;13:602-5. (Pubitemid 34983493)
29. Griffith WF, Ackerman GE, Zoellner CL, et al. Sexual assault: a report on human immunodeficiency virus postexposure prophylaxis. Obstet Gynecol Int 2010;2010. pii: 196963.
30. Lunding S, Katzenstein TL, Kronborg G, et al. The Danish PEP registry: experience with the use of postexposure prophylaxis (PEP) following sexual exposure to HIV from 1998 to 2006. Sex Transm Dis 2010;37:49-52.
31. Lacombe K, Daguenel-Nguyen A, Lebeau V, et al. Determinants of adherence to non-occupational post HIV exposure prophylaxis. AIDS 2006;20:291-4.
32. Garcia MT, Figueiredo RM, Moretti ML, et al. Postexposure prophylaxis after sexual assaults: a prospective cohort study. Sex Transm Dis 2005;32:214-19. (Pubitemid 40411576)
33. Kim JC, Askew I, Muvhango L, et al. Comprehensive care and HIV prophylaxis after sexual assault in rural South Africa: the Refentse intervention study. BMJ 2009;338:b515.
34. Abrahams N, Jewkes R, Lombard C, et al. Impact of telephonic psycho-social support on adherence to post-exposure prophylaxis (PEP) after rape. AIDS Care 2010;22:1173-81.
35. Diniz NM, de Almeida LC, dos S Ribeiro BC, et al. Women victims of sexual violence: adherence to chemoprevention of HIV. Rev Lat Am Enfermagem 2007;15:7-12.
36. Collings SJ, Bugwandeen SR, Wiles WA. HIV post-exposure prophylaxis for child rape survivors in KwaZulu-Natal, South Africa: who qualifies and who complies? Child Abuse Negl 2008;32:477-83. (Pubitemid 351626853)
37. Neu N, Heffernan-Vacca S, Millery M, et al. Postexposure prophylaxis for HIV in children and adolescents after sexual assault: a prospective observational study in an urban medical center. Sex Transm Dis 2007;34:65-8. (Pubitemid 46148607)
38. Babl FE, Cooper ER, Damon B, et al. HIV postexposure prophylaxis for children and adolescents. Am J Emerg Med 2000;18:282-7. (Pubitemid 30305284)
39. Schremmer RD, Swanson D, Kraly K. Human immunodeficiency virus postexposure prophylaxis in child and adolescent victims of sexual assault. Pediatr Emerg Care 2005;21:502-6. (Pubitemid 41193229)
40. Mills EJ, Nachega JB, Buchan I, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA 2006;296: 679-90. (Pubitemid 44200639)
41. Prevalence of HIV, total (% of population ages 15-49). http://data.worldbank.org/indicator/SH.DYN.AIDS.ZS/ (accessed 4 Feb 2012).
42. Walters DE. The need for statistical rigour when pooling data from a variety of sources. Hum Reprod 2000;15:1205-6. (Pubitemid 30251328)
43. Rucker G, Schwarzer G, Carpenter JR, et al. Undue reliance on I(2) in assessing heterogeneity may mislead. BMC Med Res Methodol 2008;8:79.
44. Abrahams N, Jewkes R. Barriers to post exposure prophylaxis (PEP) completion after rape: a South African qualitative study. Cult Health Sex 2010;12:471-84.
45. Ioannidis JP, Patsopoulos NA, Rothstein HR. Reasons or excuses for avoiding meta-analysis in forest plots. BMJ 2008;336:1413-15.
46. Egger M, Schneider M, Davey Smith G. Spurious precision? Meta-analysis of observational studies. BMJ 1998;316:140-4. (Pubitemid 28121116)